Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.

Thorac Cancer · 2020 · PMC7327672 · PMID 32421226

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = 0.070so close (0.05 < p ≤ 0.1)

Similarly, QoL in terms of physical functioning and pain showed a trend towards improvement eight weeks after initiation of treatment compared with baseline ( P = 0.070 and 0.081, respectively) (Fig 3a ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.